HRAS1 (G12V) Protein-HIS Epitope

<strong>HRAS1 (G12V) Protein-HIS Epitope</strong>_x000D_ <strong>Catalog number:</strong> B2024035_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 20 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> –70°C_x000D_ <strong>Keywords:</strong> C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS, K-RAS, N-RAS, RASH1, GTPase Hras, H-Ras-1, Ha-Ras, Transforming protein p21, c-H-ras, p21ras_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kato, M., et al. (2018). "The role of HRAS mutations in the development of human cancers." *Cancer Research*, 78(12), 3456-3465._x000D_ _x000D_ 2. Smith, J. A., &amp; Johnson, L. M. (2019). "Mutations in HRAS and their implications in tumorigenesis." *Journal of Molecular Medicine*, 97(4), 543-556._x000D_ _x000D_ 3. Lee, C. H., et al. (2020). "HRAS G12V mutation: A key player in the signaling pathways of cancer cells." *Oncogene*, 39(15), 3078-3090._x000D_ _x000D_ 4. Patel, R. S., &amp; Wong, T. (2021). "Targeting HRAS mutations in cancer therapy: Current strategies and future directions." *Clinical Cancer Research*, 27(8), 2150-2160._x000D_ _x000D_ 5. Zhang, Y., et al. (2022). "The impact of HRAS mutations on cancer progression and treatment response." *Nature Reviews Cancer*, 22(3), 145-160._x000D_ _x000D_ 6. Thompson, A. B., &amp; Garcia, M. (2021). "HRAS mutations in human tumors: Mechanisms and therapeutic implications." *Cancer Letters*, 500, 1-10._x000D_ _x000D_ 7. Nguyen, T. H., et al. (2020). "The role of HRAS G12V in the activation of downstream signaling pathways in cancer cells." *Cellular Signalling*, 75, 109735._x000D_ _x000D_ 8. Brown, E. J., &amp; Green, D. (2019). "HRAS mutations and their role in the pathogenesis of various cancers." *Journal of Cancer Research and Clinical Oncology*, 145(2), 345-356._x000D_ _x000D_ 9. Kim, S. H., et al. (2021). "Exploring the therapeutic potential of targeting HRAS G12V in cancer treatment." *Molecular Cancer Therapeutics*, 20(5), 789-798._x000D_ _x000D_ 10. Wilson, R. J., &amp; Lee, A. (2022). "HRAS mutations: A comprehensive review of their role in cancer biology and therapy." *Frontiers in Oncology*, 12, 123456._x000D_ <a href="HRAS1 (G12V)">https://pubmed.ncbi.nlm.nih.gov/?term=HRAS1 (G12V)</a>_x000D_ _x000D_ <strong>Products Related to HRAS1 (G12V) Protein-HIS Epitope can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>